Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuele Ferrari

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Blood|June 9, 2023
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cellsValentina Vavassori, Samuele Ferrari, Stefano Beretta, et al.
Nature Biotechnology|July 1, 2020
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal trackingSamuele Ferrari, Aurelien Jacob, Stefano Beretta, et al.
Nature Biotechnology|September 7, 2023
Genotoxic effects of base and prime editing in human hematopoietic stem cellsMartina Fiumara, Samuele Ferrari, Attya Omer-Javed, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 21, 2024
Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potentialLudovica Santi, Stefano Beretta, Margherita Berti, et al.
The EMBO Journal|November 2, 2023
Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4<sup>+</sup> T-cells for the treatment of Hyper IgM1Daniele Canarutto, Claudia Asperti, Valentina Vavassori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2022
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCsStefania Crippa, Anastasia Conti, Valentina Vavassori, et al.
Cell Stem Cell|March 26, 2019
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage ResponseGiulia Schiroli, Anastasia Conti, Samuele Ferrari, et al.
Nature Biotechnology|June 1, 2026
Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reportersDaniele Canarutto, Martina Fiumara, Vigneshwaran Venkatesan, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated <i>in vitro</i> and <i>in vivo</i>Claudia Asperti, Daniele Canarutto, Simona Porcellini, et al.
Science Translational Medicine|October 13, 2017
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1Giulia Schiroli, Samuele Ferrari, Anthony Conway, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Blood|June 9, 2023
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cellsValentina Vavassori, Samuele Ferrari, Stefano Beretta, et al.
Nature Biotechnology|July 1, 2020
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal trackingSamuele Ferrari, Aurelien Jacob, Stefano Beretta, et al.
Nature Biotechnology|September 7, 2023
Genotoxic effects of base and prime editing in human hematopoietic stem cellsMartina Fiumara, Samuele Ferrari, Attya Omer-Javed, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 21, 2024
Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potentialLudovica Santi, Stefano Beretta, Margherita Berti, et al.
The EMBO Journal|November 2, 2023
Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4<sup>+</sup> T-cells for the treatment of Hyper IgM1Daniele Canarutto, Claudia Asperti, Valentina Vavassori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2022
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCsStefania Crippa, Anastasia Conti, Valentina Vavassori, et al.
Cell Stem Cell|March 26, 2019
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage ResponseGiulia Schiroli, Anastasia Conti, Samuele Ferrari, et al.
Nature Biotechnology|June 1, 2026
Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reportersDaniele Canarutto, Martina Fiumara, Vigneshwaran Venkatesan, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated <i>in vitro</i> and <i>in vivo</i>Claudia Asperti, Daniele Canarutto, Simona Porcellini, et al.
Science Translational Medicine|October 13, 2017
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1Giulia Schiroli, Samuele Ferrari, Anthony Conway, et al.
Pageof 3